Your email has been successfully added to our mailing list.

×
-0.00157480314960641 -0.00157480314960641 0.0236220472440944 -0.0551181102362206 -0.0866299212598426 -0.0930708661417323 -0.0866141732283464 -0.108661417322835
Stock impact report

Therapix Bio on go to start mid-stage study of THX-110 in low back pain; shares ahead 8% premarket [Seeking Alpha]

THERAPIX BIOSCIENCES LTD AMERICAN DEPOSITARY SHARE (TRPX) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/trpx
Company Research Source: Seeking Alpha
Therapix Bio on go to start mid-stage study of THX-110 in low back pain; shares ahead 8% premarketThinly traded nano cap Therapix Biosciences (NASDAQ:TRPX) is up8% premarket on modest volume in response to itsannouncement that the FDA has signed off on its IND for THX-110 [Dronabinol (synthetic ?9-tetrahydrocannabinol) and Palmitoylethanolamide] in chronic low back pain.A single-arm, open-label Phase 2a clinical trial should commence next quarter.See all stocks on the move »Now read:Collegium: One Of The Few Winners In The Opioid Crisis » Show less Read more
Impact Snapshot
Event Time:
TRPX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for TRPX alerts
Opt-in for
TRPX alerts

from News Quantified
Opt-in for
TRPX alerts

from News Quantified